FABP5 and hepatocellular carcinoma: However, whether and how HCC cells utilize FABP5 via exosomes to specifically affect TAM lipid metabolic reprogramming, thereby shaping an immunosuppressive TME to promote HCC progression, remains an incompletely understood regulatory network.